Puerarin prevents cardiac hypertrophy induced by pressure overload through activation of autophagy

Biochemical and Biophysical Research Communications

Volumn 464, Issue 3, 2015, Pages 908-915

  Liu, Bei ^a   Wu, Zhiye ^a   Li, Yunpeng ^a   Ou, Caiwen ^a   Huang, Zhenjun ^b   Zhang, Jianwu ^a   Liu, Peng ^a   Luo, Chengfeng ^b   Chen, Minsheng ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b GUANGZHOU MEDICAL UNIVERSITY   (China)

Author keywords

AMPK; Autophagy; Cardiac hypertrophy; Puerarin

Indexed keywords

3 METHYLADENINE; GUANYLATE KINASE; INITIATION FACTOR 4E BINDING PROTEIN 1; MAMMALIAN TARGET OF RAPAMYCIN; PROTEIN S6; PUERARIN; 3-METHYLADENINE; ADENINE; CARRIER PROTEIN; EIF4EBP1 PROTEIN, RAT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; ISOFLAVONE DERIVATIVE; ISOPRENALINE; LC3 PROTEIN, RAT; MICROTUBULE ASSOCIATED PROTEIN; MTOR PROTEIN, RAT; PHOSPHOPROTEIN; S6 KINASE; TARGET OF RAPAMYCIN KINASE;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; AUTOPHAGY; CONTROLLED STUDY; DRUG EFFECT; ECHOCARDIOGRAPHY; HEART LEFT VENTRICLE OVERLOAD; HEART MUSCLE CELL; HEART VENTRICLE HYPERTROPHY; HISTOLOGY; IN VIVO STUDY; MALE; MYOBLAST; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; TREATMENT DURATION; ANALOGS AND DERIVATIVES; ANIMAL; ANTAGONISTS AND INHIBITORS; CARDIOMEGALY; DISEASE MODEL; DRUG EFFECTS; HEART MUSCLE; HEART VENTRICLE REMODELING; METABOLISM; PATHOLOGY; SPRAGUE DAWLEY RAT;

MAMMALIA; RATTUS;

ADENINE; AMP-ACTIVATED PROTEIN KINASES; ANIMALS; AUTOPHAGY; CARDIOMEGALY; CARRIER PROTEINS; DISEASE MODELS, ANIMAL; ISOFLAVONES; ISOPROTERENOL; MALE; MICROTUBULE-ASSOCIATED PROTEINS; MYOCARDIUM; MYOCYTES, CARDIAC; PHOSPHOPROTEINS; RATS, SPRAGUE-DAWLEY; RIBOSOMAL PROTEIN S6 KINASES; TOR SERINE-THREONINE KINASES; VENTRICULAR REMODELING;

EID: 84938744031     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2015.07.065     Document Type: Article

References (23)

1. P. Wojciechowski, D. Juric, X.L. Louis, S.J. Thandapilly, L. Yu, C. Taylor, and T. Netticadan Resveratrol arrests and regresses the development of pressure overload- but not volume overload-induced cardiac hypertrophy in rats J. Nutr. 140 2010 962 968
2. Y. Li, C. Chen, F. Yao, Q. Su, D. Liu, R. Xue, G. Dai, R. Fang, J. Zeng, Y. Chen, H. Huang, Y. Ma, W. Li, L. Zhang, C. Liu, and Y. Dong AMPK inhibits cardiac hypertrophy by promoting autophagy via mTORC1 Arch. Biochem. Biophys. 15 2014 79 86
3. N. Mizushima, and M. Komatsu Autophagy: renovation of cells and tissues Cell 147 2011 728 741
4. B. Levine, and G. Kroemer Autophagy in the pathogenesis of disease Cell 132 2008 27 42
5. A. Nakai, O. Yamaguchi, T. Takeda, Y. Higuchi, S. Hikoso, M. Taniike, S. Omiya, I. Mizote, Y. Matsumura, M. Asahi, K. Nishida, M. Hori, N. Mizushima, and K. Otsu The role of autophagy in cardiomyocytes in the basal state and in response to hemodynamic stress Nat. Med. 13 2007 619 624
6. C. Liu, R. Xue, D. Wu, L. Wu, C. Chen, W. Tan, Y. Chen, and Y. Dong REDD1 attenuates cardiac hypertrophy via enhancing autophagy Biochem. Biophys. Res. Commun. 454 2014 215 220
7. H.L. Chen, X. Wang, M.M. Tong, D. Wu, S.S. Wu, J.X. Chen, X.X. Wang, X.L. Wang, Y. Kang, H. Tang, C.S. Tang, and W. Jiang Intermedin Suppresses Pressure Overload Cardiac Hypertrophy through Activation of Autophagy PLoS One 8 2013 e64757
8. Y.X. Zhou, H. Zhang, and C. Peng Puerarin: A Review of Pharmacological Effects Phytother. Res. 28 2014 961 975
9. J. Li, R. Liu, Y. Lei, K. Wang, Q.C. Lau, N. Xie, S. Zhou, C. Nie, L. Chen, Y. Wei, and C. Huang Proteomic analysis revealed association of aberrant ROS signaling with suberoylanilide hydroxamic acidinduced autophagy in Jurkat T-leukemia cells Autophagy 6 2010 711 724
10. H. He, M. Shi, J. Yang, X. Zeng, H. Qiao, L. Wu, and L. Li The correlation between angiogenesis and abnormal expression of SERCA2a, phosphorlamban and the endothelin pathway in heart failure, and improvement by puerarin Phytother. Res. 22 2008 948 956
11. G. Chen, S.Q. Pan, C. Shen, S.F. Pan, X.M. Zhang, and Q.Y. He Puerarin inhibits angiotensin II-induced cardiac hypertrophy via the redox-sensitive ERK1/2, p38 and NF-κB pathways Acta. Pharmacol. Sin. 35 2014 463 475
12. R. Chen, J. Xue, and M. Xie Puerarin prevents isoprenaline-induced myocardial fibrosis in mice by reduction of myocardial TGF-β1 expression J. Nutr. Biochem. 23 2012 1080 1085
13. Y. Yuan, J. Zong, H. Zhou, Z.Y. Bian, W. Deng, J. Dai, H.W. Gan, Z. Yang, H. Li, and Q.Z. Tang Puerarin attenuates pressure overload-induced cardiac hypertrophy J. Cardiol. 63 2014 73 81
14. B.A. Rothermel, and J.A. Hill Autophagy in Load-Induced Heart Disease Circ. Res. 103 2008 1363 1369
15. H. Zhu, P. Tannous, J.L. Johnstone, Y. Kong, J.M. Shelton, J.A. Richardson, V. Le, B. Levine, B.A. Rothermel, and J.A. Hill Cardiac autophagy is a maladaptive response to hemodynamic stress J. Clin. Invest 117 2007 1782 1793
16. J.A. Kuzman, T.D. O'Connell, and A.M. Gerdes Rapamycin prevents thyroid hormone-induced cardiac hypertrophy Endocrinology 148 2007 3477 3484
17. X. Chen, S.Y. Zeng, J. Zou, Y.F. Chen, Z.B. Yue, Y. Gao, L.K. Zhang, W.W. Cao, and P.Q. Liu Rapamycin attenuated cardiac hypertrophy induced by isoproterenol and maintained energy homeostasis via inhibiting NF-κB activation Mediat. Inflamm. 2014 2014 868753
18. X.C. Wang, X. Wang, and Q.L. Li Effect of chaperone-mediated autophagy in MPP(+) -induced SH-SY5Y cells and interventional effect of puerarin Zhong Guo Zhong Yao Za Zhi 39 2014 106 112
19. B.K. Noh, J.K. Lee, H.J. Jun, J.H. Lee, Y.Y. Jia, M.H. Hoang, J.W. Kim, K.H. Park, and S.J. Lee Restoration of autophagy by puerarin in ethanol-treated hepatocytes via the activation of AMP-activated protein kinase Biochem. Biophys. Res. Commun. 414 2011 361 366
20. P. Zhang, X. Hu, X. Xu, J. Fassett, G. Zhu, B. Viollet, W. Xu, B. Wiczer, D.A. Bernlohr, R.J. Bache, and Y. Chen AMP activated protein kinase-alpha2 deficiency exacerbates pressure-overload-induced left ventricular hypertrophy and dysfunction in mice Hypertension 52 2008 918 924
21. Y. Ikeda, K. Sato, D.R. Pimentel, F. Sam, R.J. Shaw, J.R. Dyck, and K. Walsh Cardiac-specific deletion of LKB1 leads to hypertrophy and dysfunction J. Biol. Chem. 284 2009 35839 35849
22. N. Jessen, H.J. Koh, C.D. Folmes, C. Wagg, N. Fujii, B. Løfgren, C.M. Wolf, C.I. Berul, M.F. Hirshman, G.D. Lopaschuk, and L.J. Goodyear Ablation of LKB1 in the heart leads to energy deprivation and impaired cardiac function Biochim. Biophys. Acta 1802 2010 593 600
23. C.Y. He, H.P. Zhu, H.L. Li, M.H. Zou, and Z.L. Xie Dissociation of Bcl-2-Beclin1 Complex by Activated AMPK Enhances Cardiac Autophagy and Protects Against Cardiomyocyte Apoptosis in Diabetes Diabetes 62 2013 1270 1281